An Open-Label Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients withFacioscapulohumeral Muscular Dystrophy (FSHD) Previously Enrolled in Stsudy A083-02 and in Patientswith Charcot-Marie-Tooth (CMT) Disease Types 1 and X Previousl

Project: Research project

Project Details

Description

An Open-Label Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients with Facioscapulohumeral Muscular Dystrophy (FSHD) Previously Enrolled in Stsudy A083-02 and in Patients with Charcot-Marie-Tooth (CMT) Disease Types 1 and X Previousl
StatusActive
Effective start/end date3/1/192/28/22

Funding

  • ACCELERON PHARMA INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.